PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS

Overview Fund Activity
Delisted

PHAS was delisted on the 2nd of November, 2022.

Back to rankings

58 hedge funds and large institutions have $53M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 3 closing their positions.

Holders
58
Holders Change
+8
Holders Change %
+16%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
17
Reduced
16
Closed
3
Calls
$239K
Puts
$1K
Net Calls
+$238K
Net Calls Change
+$177K

Top Buyers

1
PHP
1
Parkman Healthcare Partners
Connecticut
$371K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$280K
3
William Blair & Company
3
William Blair & Company
Illinois
$227K
4
BlackRock
4
BlackRock
New York
$4.01M
5
PTP
5
Platform Technology Partners
New York
$474K

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$5.27M
2
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$0
3
BCM
3
Bridgeway Capital Management
Texas
$429K
4
State Street
4
State Street
Massachusetts
$934K
5
WS
5
Wedbush Securities
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
NMC
1
NEA Management Company
Maryland
$22.3M 6,643,704 – –
JJIJ
2
Johnson & Johnson Innovation - JJDC
New Jersey
$5.4M 1,607,044 – –
Wellington Management Group
3
Wellington Management Group
Massachusetts
$5.27M 1,567,656 -1,761,606 -53%
RSCM
4
Rock Springs Capital Management
Maryland
$4.42M 1,314,374 +1,200 +0.1%
BlackRock
5
BlackRock
New York
$4.01M 1,193,607 +58,668 +5%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.56M 761,927 +33,249 +5%
DCM
7
DAFNA Capital Management
California
$1.08M 320,542 – –
State Street
8
State Street
Massachusetts
$934K 277,957 -22,800 -8%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$779K 232,036 -4,156 -2%
Stifel Financial
10
Stifel Financial
Missouri
$706K 210,125 +22,288 +12%
Northern Trust
11
Northern Trust
Illinois
$556K 165,340 -1,599 -1%
PTP
12
Platform Technology Partners
New York
$474K 141,025 +48,075 +52%
GCP
13
GSA Capital Partners
United Kingdom
$472K 140,341 -13,975 -9%
BCM
14
Bridgeway Capital Management
Texas
$429K 127,600 -25,000 -16%
PHP
15
Parkman Healthcare Partners
Connecticut
$371K 110,547 +110,547 New
Morgan Stanley
16
Morgan Stanley
New York
$365K 108,449 +6,799 +7%
Nuveen Asset Management
17
Nuveen Asset Management
Illinois
$332K 98,856 +154 +0.2%
Renaissance Technologies
18
Renaissance Technologies
New York
$280K 83,400 +83,400 New
William Blair & Company
19
William Blair & Company
Illinois
$227K 67,500 +67,500 New
SM
20
Sabby Management
Florida
$218K 65,000 -14,470 -18%
Millennium Management
21
Millennium Management
New York
$187K 55,753 +26,501 +91%
SFI
22
Susquehanna Fundamental Investments
Pennsylvania
$161K 47,970 -10,732 -18%
AllianceBernstein
23
AllianceBernstein
Tennessee
$146K 43,500 – –
JPMorgan Chase & Co
24
JPMorgan Chase & Co
New York
$138K 41,006 +35,284 +617%
Charles Schwab
25
Charles Schwab
California
$137K 40,648 – –
1
2 3